Evaluation of Antireflux Mucosectomy for Severe Gastroesophageal Reflux Disease: Medium-Term Results of a Pilot Study.

Arthur LaquièreFelix Trottier-TellierRomina Urena-CamposPascal LienneLaurence LecomteMaria KatsogiannouGuillaume PenarandaChristian Boustière

Published in: Gastroenterology research and practice (2022)

In patients with severe gastroesophageal reflux disease, despite occurrence of several short-term adverse events, antireflux mucosectomy seemed effective in improving gastroesophageal reflux disease symptoms at 24 months. This trial is registered with ClinicalTrials: NCT03357809.

Keyphrases

gastroesophageal reflux disease
early onset
risk assessment
study protocol
clinical trial
phase iii
randomized controlled trial
drug induced
sleep quality
gestational age